Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type I gene mutations [1] (multiple letters)

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 568-571

  Monno, L ^a   Appice, A ^a   Cavaliere, R ^a   Scarabaggio, T ^a   Angarano, G ^a   Young, B ^a   Kuritzkes, D R ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; INDINAVIR; LAMIVUDINE; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

CLINICAL ARTICLE; DRUG SENSITIVITY; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT FAILURE;

EID: 0033509030     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314909     Document Type: Letter

References (0)